Wednesday, July 30, 2025
News Health
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health
No Result
View All Result
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health
No Result
View All Result
HealthNews
No Result
View All Result
Home Health News

Rx Delayed in Half of US Children With Vitiligo

July 7, 2025
in Health News
Share on FacebookShare on Twitter


TOPLINE:

In a US real-world analysis, only 51.5% of children with vitiligo received any treatment within 2 years of diagnosis, less often than adults.

METHODOLOGY:

  • Researchers analyzed data from the TriNetX US Collaborative Network of patients with two or more medical claims for vitiligo.
  • The study included 5253 adults and an equal number of sex- and race-matched pediatric patients.
  • Treatment included phototherapies (narrowband ultraviolet [UVB], psoralen and UVA [PUVA], and excimer laser), topical treatments (calcineurin inhibitors, corticosteroids, calcipotriene, and ruxolitinib), and systemic therapies (corticosteroids and oral immunomodulators).
  • Outcomes were prescribing patterns in children within 1 year of diagnosis and treatment initiation rates in adult and pediatric patients within 2 years post-diagnosis.

TAKEAWAY:

  • In 2024, topical corticosteroids were the most commonly prescribed treatment in children (73.0%), followed by systemic corticosteroids (57.0%), topical calcineurin inhibitors (49.8%), and topical ruxolitinib (11.3%), approved by the FDA for treating nonsegmental vitligo in patients aged 12 years or older.
  • Within 2 years of diagnosis, 51.5% of pediatric and 56.1% of adult patients received treatment, indicating that treatment initiation rates were significantly lower among pediatric patients than among adult patients (hazard ratio [HR], 0.91; 95% CI, 0.86-0.96).
  • Pediatric patients had lower treatment initiation rates across all modalities than adults: phototherapy (HR, 0.82; 95% CI, 0.71-0.94), topical treatment (HR, 0.92; 95% CI, 0.87-0.97), and systemic therapy (HR, 0.63; 95% CI, 0.59-0.67).

IN PRACTICE:

This study showed that “48.5% of children with vitiligo remained treatment-free within 2 years post-diagnosis” and had a lower probability of starting treatment than adults, the authors wrote. Factors that might contribute to this difference, they added, included disease recognition, considering lack of access to pediatric dermatology care in some areas, and “insurance providers classifying vitiligo as a cosmetic rather than medical condition leading to limited coverage and access, particularly to newer therapies.”

SOURCE:

This study was led by Serena Yun-Chen Tsai, MD, MMSc, Department of Dermatology, Massachusetts General Hospital, Boston. It was published online on July 2 in the Journal of the American Academy of Dermatology.

LIMITATIONS:

This study relied on coded diagnoses and excluded patients with only one encounter, possibly inflating treatment rates. Disease severity, location, and care outside TriNetX sites were not captured.

DISCLOSURES:

The authors reported having no funding information. One author received funding from the Society for Pediatric Dermatology/Pediatric Dermatology Research Alliance. Two authors reported receiving advisory fees and having ties with Alys Pharmaceuticals, Avoro, Barinthus Bio NA, Cour Pharma, Incyte, Matchpoint Therapeutics, NexImmune, Vividion, and Sanofi.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.



Source link : https://www.medscape.com/viewarticle/study-treatment-delayed-half-us-children-vitiligo-2025a1000hwk?src=rss

Author :

Publish date : 2025-07-07 13:08:00

Copyright for syndicated content belongs to the linked Source.

Previous Post

MHRA Approves New Immunotherapy for Bladder Cancer

Next Post

Republicans Muscle Trump’s Sweeping Tax Cut, Spending Bill

Related Posts

Health News

Managing CKD-Associated Pruritus

July 30, 2025
Health News

Food hygiene advice offered after E.coli infections rise

July 30, 2025
Health News

Congressman Kicked by Horse; Senate Dems Launch Probe of RFK Jr.; NIH Funding Fight

July 30, 2025
Health News

Novel Peptides Expressed in HIV Could Drive Treatment

July 30, 2025
Health News

FDA’s Top Vaccine Chief Resigns

July 30, 2025
Health News

Private-Equity Raises Colonoscopy Costs but Not Quality

July 30, 2025
Load More

Managing CKD-Associated Pruritus

July 30, 2025

Food hygiene advice offered after E.coli infections rise

July 30, 2025

Congressman Kicked by Horse; Senate Dems Launch Probe of RFK Jr.; NIH Funding Fight

July 30, 2025

Novel Peptides Expressed in HIV Could Drive Treatment

July 30, 2025

FDA’s Top Vaccine Chief Resigns

July 30, 2025

Private-Equity Raises Colonoscopy Costs but Not Quality

July 30, 2025

CAC of Zero? Try to Keep It That Way

July 30, 2025

Repairing the Aging Blood-Brain Barrier: Real Possibilities

July 30, 2025
Load More

Categories

Archives

July 2025
MTWTFSS
 123456
78910111213
14151617181920
21222324252627
28293031 
« Jun    

© 2022 NewsHealth.

No Result
View All Result
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health

© 2022 NewsHealth.

Go to mobile version